Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Advanced Renal Cell Carcinoma (aRCC)
20%
Anti-PD-1 Therapy
20%
Anti-PD-1/PD-L1 Therapy
20%
Anti-programmed Cell Death Protein 1 (anti-PD-1)
100%
BACH2
20%
Cancer Cell Lines
20%
CCL3
20%
CD4+ T Cell Differentiation
20%
Cell-intrinsic
20%
Clinical Outcomes
20%
Combination Therapy
20%
Family Members
20%
Formalin-fixed Paraffin-embedded
20%
Gene Expression
100%
Gene Expression Analysis
20%
Gene Expression Profile
20%
Genome-wide Microarray
20%
Immune Function
20%
Immune Markers
20%
Kidney Cancer Cell
20%
Metabolic
100%
Metabolic Factors
20%
Metabolic Pathways
20%
Metabolic Transport
20%
Multiplex
20%
New Targets
20%
PD-L1 Expression
20%
Predictive Marker
20%
Programmed Cell Death Protein 1 (PD-1)
20%
Programmed Death-ligand 1 (PD-L1)
100%
Quantitative PCR
20%
Renal Cell Carcinoma
100%
Solute Transport
20%
Targeted Therapy
20%
Therapy Regimen
20%
Transendothelial Migration
20%
Transport Function
20%
Treatment Failure
20%
Treatment Outcome
20%
Treatment Potential
20%
Treatment Resistance
20%
Tumor
80%
Tumor Biopsy
20%
Tumor Cells
20%
UGT1A1
20%
Medicine and Dentistry
Cancer Cell Line
14%
Clear Cell Renal Cell Carcinoma
100%
Combination Therapy
14%
Formaldehyde
14%
Gene Expression
100%
Gene Expression Profiling
14%
Immune Function
14%
Kidney Cancer
14%
Leukocyte Migration
14%
Metabolic Pathway
14%
Neoplasm
14%
Predictive Marker
14%
Programmed Death-Ligand 1
100%
Reverse Transcription Polymerase Chain Reaction
14%
T Cell Differentiation
14%
T-Helper Cell
14%
Targeted Therapy
14%
Treatment Outcome
14%
Tumor
42%
Tumor Biopsy
14%
Tumor Cell
14%